组织供体变量与原发性半月板同种异体移植术后临床显著结局、再手术及失败之间的关联
该病例系列(证据等级4)前瞻性随访2003至2022年245例原发性半月板同种异体移植患者,平均随访8.4年,分析供体性别、年龄及供受体性别错配对临床显著结局、再手术和失败的影响。结果显示供体变量均不能预测5年IKDC临床显著结局,再手术和失败生存率也无差异;作者认为性别匹配并非移植物选择所必需。
要点
- 供体性别、年龄及供受体性别错配均不能预测5年IKDC临床显著结局。
- 供体变量与再手术或失败的生存率之间未观察到差异。
- 作者认为性别匹配并非移植物选择所必需,可能增加同种异体移植物可用性。
核心结论
- 供体变量(包括性别、年龄及供受体性别错配)未对临床结局产生负面影响。
- 作者认为性别匹配并非移植物选择所必需,可能增加同种异体移植物可用性并促进供体有限时的半月板同种异体移植。
研究设计与样本
- 研究为病例系列,证据等级4。
- 2003至2022年间前瞻性随访接受原发性半月板同种异体移植且随访至少2年的患者。
- 共245例患者符合纳入标准,平均随访8.4±4.2年(范围2.0-19.1年)。
- 247膝中73膝(30%)行孤立性半月板同种异体移植。
主要发现
- 接受对侧性别供体移植物的女性膝(89/129[69%])显著多于男性膝(10/118[9%])(P < .001)。
- 性别错配组移植物接受者平均年龄小于非错配组(25.4±8.5 vs 28.6±8.8岁;P = .004)。
- 无供体变量能预测5年时达到IKDC临床显著结局。
- 再手术或失败的生存率未观察到差异。
关键数值与推荐
- 临床显著结局依据国际膝关节文献委员会(IKDC)评分评估。
- 再手术定义为涉及移植物的任何手术干预,包括复发症状或功能缺陷时的二次关节镜手术、半月板切除和半月板修复。
- 失败定义为翻修半月板同种异体移植和单间室或全膝关节置换。
- 生存率采用Kaplan-Meier曲线评估,组间比较采用对数秩检验。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Donor-recipient sex mismatch for tissue and organ transplantation has been shown to negatively affect outcomes. PURPOSE: To analyze the effect of sex mismatching on outcomes after meniscal allograft transplantation (MAT) and to determine if there is an association between the sex of the recipient and the sex of the donor and how this affects clinically significant outcome (CSO), reoperation, and failure rates after primary MAT. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Between 2003 and 2022, patients who underwent MAT were prospectively followed, with the inclusion criteria of having undergone primary MAT and having a minimum of 2 years' follow-up. Patient characteristics and clinical data, as well as donor age, donor sex, and graft expiration date, were collected. Reoperation and failure data were also collected, and patients were evaluated for achieving CSOs for the International Knee Documentation Committee (IKDC) score. A reoperation was any surgical intervention involving the transplanted allograft, including second-look arthroscopic surgery in the setting of recurrent symptoms or functional deficits, meniscectomy, and meniscal repair. Failure was defined as revision MAT and unicompartmental or total knee arthroplasty. Survivorship was assessed with a Kaplan-Meier curve. Log-rank testing evaluated survivorship between groups. RESULTS: A total of 245 patients met the inclusion criteria and were followed for a mean of 8.4 ± 4.2 years (range, 2.0-19.1 years). Isolated MAT was performed in 73 of 247 knees (30%). There was a significantly greater prevalence of female knees (89/129 [69%]) than male knees (10/118 [9%]) that received a graft from the opposite sex (P < .001). On average, graft recipients were younger in the mismatch group than in the nonmismatch group (25.4 ± 8.5 vs 28.6 ± 8.8 years, respectively; P = .004). No donor variables were predictive of achieving CSOs for the IKDC score at 5 years. No difference in rates of survivorship from reoperations or failure was observed. CONCLUSION: Donor variables, including sex, age, and donor-recipient sex mismatch, did not negatively affect clinical outcomes. These findings suggest that sex matching is not necessary for graft selection, potentially increasing the availability of allografts and facilitating MAT in the setting of limited donor availability.
引用
- Muth SA, Franzia CH, Mufti YN, et al. Associations Between Tissue Donor Variables and Clinically Significant Outcomes, Reoperations, and Failure After Primary Meniscal Allograft Transplantation. Am J Sports Med. 2025. PMID: 41055105. doi:10.1177/03635465251376580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。